Aeterna Wealth
Sectoral/Thematic · Regular plan · Growth

PGIM India Healthcare Fund (Regular)

PGIM India Mutual Fund · benchmark Nifty 500 TRI · 1.9 years old · AMFI code 153040

–
Track-record rating

Not rated yet: a rating needs at least 3 years of history (1 year for index funds).

Returns against the index

PeriodFundIndex (TRI)DifferenceRank in category
6 months15.5%2.5%+13.0%7 / 17
1 year18.6%-1.0%+19.6%5 / 16
3 years (a year)––––
5 years (a year)––––

Growth option, point to point to 5 Nov 2026; periods over a year are annualised (CAGR). Index returns use the total-return index, which includes dividends.

Risk

Portfolio

Divi's Laboratories Ltd.10.4%
Sun Pharmaceutical Industries Ltd.10.2%
Torrent Pharmaceuticals Ltd.8.5%
Ajanta Pharma Ltd.5.0%
Max Healthcare Institute Ltd.4.7%
Dr. Lal Path Labs Ltd.4.3%
Mankind Pharma Ltd.4.0%
Manipal Health Enterprises Ltd.3.7%
Navin Fluorine International Ltd.3.2%
Abbott India Ltd.3.1%

Top 10 holdings, September 2026 portfolio.

Common questions

What is the NAV of PGIM India Healthcare Fund (Regular plan)?

₹12.01 on 5 Nov 2026 (Growth option).

What is the expense ratio of PGIM India Healthcare Fund (Regular)?

2.65% a year; the Direct plan's is 0.98%.

What does PGIM India Healthcare Fund invest in?

Its largest holdings are Divi's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., with 31 stocks in all (September 2026 portfolio).

Data as of 5 Nov 2026: NAVs from AMFI, index data from NSE Indices, portfolios from PGIM India Mutual Fund's monthly disclosure. Updated every weekday. Read the scheme documents before investing.